Article
Follow up study of infants recruited to the randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants – Study protocol for the AZTEC-FU Study
2022-06-22
Abstract excerpt
<h4>Background: </h4> Preterm birth, especially at less than 30 weeks’ gestation, is significantly associated with respiratory, neurodevelopmental and growth abnormalities. The AZTEC study has recruited 799 infants born at <30 weeks’ gestation to determine if a ten-day intravenous treatment with azithromycin improves survival without development of chronic lung disease of prematurity (CLD) at 36 weeks’ post menstr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7f56a3ed-50f2-50cc-baec-ad85b3933770
- DOI
- 10.21203/rs.3.rs-1593914/v1
